This study, called GETSET, is looking at how preimplantation genetic testing for aneuploidy (PGT-A) affects pregnancy rates in women undergoing in vitro fertilization (IVF). PGT-A is a test that screens embryos for an abnormal number of chromosomes before they are transferred. You may be able to join if you are a woman between 35 and 40 years old, undergoing IVF with your own eggs, and using either ejaculated or testicular sperm. The main goal is to see if PGT-A leads to a higher ongoing pregnancy rate, which will be measured for up to two years. The current recruitment status is unclear.

Study design

This is a randomized controlled trial, meaning participants will be assigned by chance to one of two groups. About 240 women will participate in this study.

What's involved

You would undergo standard IVF procedures including ovarian hyper-stimulation, egg retrieval, fertilization, and embryo culture. Depending on your assigned group, your embryos may undergo PGT-A testing before a single embryo transfer.

Compensation

Not stated in the trial record.

Follow-up

Your ongoing pregnancy rate will be measured for up to two years after the embryo transfer.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.